ES2188795T3 - Agentes antimicrobianos benzoxacina. - Google Patents
Agentes antimicrobianos benzoxacina.Info
- Publication number
- ES2188795T3 ES2188795T3 ES96936648T ES96936648T ES2188795T3 ES 2188795 T3 ES2188795 T3 ES 2188795T3 ES 96936648 T ES96936648 T ES 96936648T ES 96936648 T ES96936648 T ES 96936648T ES 2188795 T3 ES2188795 T3 ES 2188795T3
- Authority
- ES
- Spain
- Prior art keywords
- benzoxacine
- antimicrobial agents
- group
- those
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
LA INVENCION ESTA RELACIONADA CON UNOS COMPUESTOS ANTIBACTERIANOS DE BENZOXACINA Y PIRIDOXACINA CON LA FORMULA GENERAL (1), EN LA QUE EL GRUPO Q CORRESPONDE A UN GRUPO FENILO O PIRIDILO UNIDO, TAL COMO SE DESCRIBE MAS ADELANTE, ASI COMO UNAS COMPOSICIONES FARMACEUTICAS QUE CONTENGAN ESTOS COMPUESTOS, UNOS METODOS PARA SU PRODUCCION Y SU USO EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/553,188 US5696117A (en) | 1995-11-07 | 1995-11-07 | Benzoxazine antimicrobial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188795T3 true ES2188795T3 (es) | 2003-07-01 |
Family
ID=24208465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96936648T Expired - Lifetime ES2188795T3 (es) | 1995-11-07 | 1996-10-17 | Agentes antimicrobianos benzoxacina. |
Country Status (24)
Country | Link |
---|---|
US (2) | US5696117A (es) |
EP (1) | EP0869949B1 (es) |
JP (1) | JP2000500134A (es) |
KR (1) | KR100503910B1 (es) |
AR (1) | AR004706A1 (es) |
AT (1) | ATE229944T1 (es) |
AU (1) | AU720743B2 (es) |
BR (1) | BR9611400A (es) |
CZ (1) | CZ137998A3 (es) |
DE (1) | DE69625515T2 (es) |
DK (1) | DK0869949T3 (es) |
ES (1) | ES2188795T3 (es) |
HU (1) | HUP9901184A3 (es) |
IL (1) | IL124337A (es) |
MX (1) | MX9803650A (es) |
MY (1) | MY128650A (es) |
NO (1) | NO311026B1 (es) |
NZ (1) | NZ321251A (es) |
PL (1) | PL189987B1 (es) |
RU (1) | RU2191179C2 (es) |
SK (2) | SK285388B6 (es) |
TW (1) | TW536537B (es) |
WO (1) | WO1997017333A1 (es) |
ZA (1) | ZA969326B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265401B1 (en) * | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
CA2307068C (en) | 1997-10-27 | 2007-04-10 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
WO1999052861A1 (de) * | 1998-04-09 | 1999-10-21 | Institut für Diagnostikforschung GmbH an der Freien Universität Berlin | Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik |
US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
WO2001012600A1 (en) * | 1999-08-12 | 2001-02-22 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
EP1280782A2 (en) * | 2000-05-12 | 2003-02-05 | Ortho-McNeil Pharmaceutical, Inc. | Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment |
EP1280783A2 (en) * | 2000-05-12 | 2003-02-05 | Ortho-McNeil Pharmaceutical, Inc. | Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators |
US6908908B2 (en) * | 2000-05-12 | 2005-06-21 | Ortho-Mcneil Pharmaceutical, Inc. | Biologically active 4H-benzo [1,4] oxazin-3-ones |
MY141659A (en) | 2000-05-12 | 2010-05-31 | Ortho Mcneil Pharm Inc | Biologically active 4h-benzo[1,4]oxazin-3-ones. |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
US20050266575A1 (en) * | 2004-05-27 | 2005-12-01 | Mayo Kevin H | Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics |
WO2006082495A1 (en) * | 2005-02-02 | 2006-08-10 | Ranbaxy Laboratories Limited | Peroxisome proliferator activated receptor modulators |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
EP1985297A1 (en) * | 2006-01-27 | 2008-10-29 | Japan Tobacco, Inc. | Carboxylic acid compound and use thereof |
US20070197512A1 (en) * | 2006-01-27 | 2007-08-23 | Japan Tobacco Inc. | Carboxylic Acid Compounds and Use Thereof |
JP5099814B2 (ja) * | 2006-02-02 | 2012-12-19 | 田辺三菱製薬株式会社 | 含窒素複素二環式化合物 |
TWI385161B (zh) * | 2006-02-02 | 2013-02-11 | Mitsubishi Tanabe Pharma Corp | 含氮雜雙環化合物 |
EP2063905B1 (en) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
TWI410410B (zh) | 2007-08-10 | 2013-10-01 | Ono Pharmaceutical Co | Phenylacetic acid compounds |
CA2969926C (en) | 2009-02-20 | 2018-05-15 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
BRPI1015525A2 (pt) * | 2009-04-14 | 2015-09-01 | Nissan Chemical Ind Ltd | Derivados de haloalquilsulfonanilida, seus usos, seus intermediários e seu método de uso, bem como agroquímico e herbicida |
EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
US9493452B2 (en) | 2011-03-24 | 2016-11-15 | Southern Methodist University | Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors |
US8669363B2 (en) | 2011-03-24 | 2014-03-11 | Southern Methodist University | Quinoxaline compounds and derivatives |
WO2013142831A1 (en) | 2012-03-23 | 2013-09-26 | Southern Methodist University | Methods of making and using thioxothiazolidine and rhodanine derivatives as hiv-1 and jsp-1 inhibitors |
GB2533925A (en) * | 2014-12-31 | 2016-07-13 | Univ Bath | Antimicrobial compounds, compositions and methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3635956A (en) * | 1968-03-01 | 1972-01-18 | Squibb & Sons Inc | Benzothiazines related compounds derivatives and salts thereof |
US3725403A (en) * | 1970-10-20 | 1973-04-03 | Squibb & Sons Inc | Benzothiazine derivatives |
JPS5547006B2 (es) * | 1973-04-04 | 1980-11-27 | ||
FR2588868B1 (fr) * | 1985-10-21 | 1988-11-10 | Negma Laboratoires | Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant |
EP0233728A1 (en) * | 1986-02-11 | 1987-08-26 | Takeda Chemical Industries, Ltd. | 1,4-Benzoxazine derivatives their production and use |
DE4304806A1 (de) * | 1993-02-17 | 1994-08-18 | Kali Chemie Pharma Gmbh | 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1995
- 1995-11-07 US US08/553,188 patent/US5696117A/en not_active Expired - Lifetime
-
1996
- 1996-10-17 PL PL96326704A patent/PL189987B1/pl not_active IP Right Cessation
- 1996-10-17 DE DE69625515T patent/DE69625515T2/de not_active Expired - Fee Related
- 1996-10-17 WO PCT/US1996/016669 patent/WO1997017333A1/en not_active Application Discontinuation
- 1996-10-17 CZ CZ981379A patent/CZ137998A3/cs unknown
- 1996-10-17 BR BR9611400-2A patent/BR9611400A/pt not_active IP Right Cessation
- 1996-10-17 AT AT96936648T patent/ATE229944T1/de not_active IP Right Cessation
- 1996-10-17 ES ES96936648T patent/ES2188795T3/es not_active Expired - Lifetime
- 1996-10-17 EP EP96936648A patent/EP0869949B1/en not_active Expired - Lifetime
- 1996-10-17 SK SK1033-2002A patent/SK285388B6/sk not_active IP Right Cessation
- 1996-10-17 KR KR10-1998-0703405A patent/KR100503910B1/ko not_active IP Right Cessation
- 1996-10-17 SK SK597-98A patent/SK283888B6/sk not_active IP Right Cessation
- 1996-10-17 AU AU74519/96A patent/AU720743B2/en not_active Ceased
- 1996-10-17 HU HU9901184A patent/HUP9901184A3/hu unknown
- 1996-10-17 JP JP9518188A patent/JP2000500134A/ja not_active Ceased
- 1996-10-17 DK DK96936648T patent/DK0869949T3/da active
- 1996-10-17 NZ NZ321251A patent/NZ321251A/en unknown
- 1996-10-17 RU RU98110572/04A patent/RU2191179C2/ru not_active IP Right Cessation
- 1996-10-17 IL IL12433796A patent/IL124337A/en not_active IP Right Cessation
- 1996-11-06 ZA ZA9609326A patent/ZA969326B/xx unknown
- 1996-11-06 AR ARP960105075A patent/AR004706A1/es active IP Right Grant
- 1996-11-07 MY MYPI96004648A patent/MY128650A/en unknown
- 1996-11-25 TW TW085114485A patent/TW536537B/zh not_active IP Right Cessation
-
1997
- 1997-07-23 US US08/899,235 patent/US5854242A/en not_active Expired - Lifetime
-
1998
- 1998-05-06 NO NO19982071A patent/NO311026B1/no not_active IP Right Cessation
- 1998-05-07 MX MX9803650A patent/MX9803650A/es not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188795T3 (es) | Agentes antimicrobianos benzoxacina. | |
ES2152701T3 (es) | Composiciones acuosas desinfectantes y de limpieza. | |
ES2164182T3 (es) | Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana. | |
BR9900320A (pt) | Composição antimicrobiana | |
GT199900157A (es) | Herbicidas novedosos. | |
MA27643A1 (fr) | Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens | |
BR9407711A (pt) | Composto de ciclopeptídeo processo para preparaçao de um composto de ciclopeptídeo e parasiticida | |
DE69841512D1 (de) | Metalle/Thiole enthaltende biozide Mittel | |
BR0213010A (pt) | Aminopirimidinas substituìdas com tiazolila como agentes de proteção de plantas | |
BR9205902A (pt) | Composto e processo para preparar o mesmo, composição fungicida e processo para combater fungos | |
DE602005023901D1 (de) | Zusammensetzungen mit hoher antiviraler und antibakterieller wirkung | |
DK0920421T3 (da) | Isoxazolinderivater anvendelige som antimikrobielle midler | |
ES2153076T3 (es) | Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos. | |
ES2195397T3 (es) | Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos. | |
AR034949A1 (es) | Composicion fungicida y utilizacion de esta composicion para controlar las enfermedades de las plantas | |
ES2178761T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas. | |
BR9006340A (pt) | Compostos,composicao fungicida,processo para a preparacao de compostos,processo para combater fungus e aplicacao | |
DK0865424T3 (da) | Pesticider | |
PT96585A (pt) | Processo para prparacao de uma composicao microbiocida para tratamento de telhas de betao | |
AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. | |
AP2001002165A0 (en) | Use of phosphonoformic acid derivatives for treating infections | |
AR023644A1 (es) | 3-aril-pirazoles substituidos, procedimiento para su obtencion, procedimiento para la lucha contra plantas indeseables, empleo de los mismos contra plantasindeseables y/o como fungicida, y composicion para el tratamiento de plantas | |
UY27394A1 (es) | Pedidos con actividad anti- angiogéna. | |
ES2154692T3 (es) | Dihidrofarnesal. | |
ATE250338T1 (de) | Antiseptische zusammensetzungen |